Labcorp Holdings Inc.
Organization details
- Legal name
- Labcorp Holdings Inc.
- Former names
- Laboratory Corp of America Holdings National Health Laboratories Holdings Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Headquarters city
- Burlington
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LH
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000920148
- EIN
- 99-2588107
- Wikidata ID
- Q6466630
Board of directors
-
Adam H. Schechter · Director · President & CEOSince 2023
-
Carulla Victor Bulto · DirectorSince 2025
-
Dwight Gary Gilliland · DirectorSince 2023
-
Garheng Kong · DirectorSince 2023
-
Jean-Luc Belingard · DirectorSince 2023
-
Jeffrey A. Davis · DirectorSince 2023
-
John H. Sampson · DirectorSince 2026
-
Kathryn E. Wengel · DirectorSince 2023
-
Kerrii B. Anderson · DirectorSince 2023
-
Kirsten Marie Kliphouse · DirectorSince 2023
-
Paul Rothman · DirectorSince 2023
-
Peter M. Neupert · DirectorSince 2023
-
R. Sanders Williams · DirectorSince 2023
-
Richelle P. Parham · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
71.4%
-
92.5%
-
93.0%
-
93.5%
-
96.1%
-
99.5%
-
99.5%
-
99.9%
-
99.9%
-
100.0%
Board connections
9 of this board's directors also sit on 13 other boards. 7 are in the same sector.
- via Kerrii B. Anderson
-
Adaptive Biotechnologies Corporation Same sectorvia Peter M. Neupert
-
Amgen Inc. Same sectorvia R. Sanders Williams
- via Richelle P. Parham
-
DaVita Inc. Same sectorvia Adam H. Schechter
- via Jeffrey A. Davis
-
Fortrea Holdings Inc. Same sectorvia Peter M. Neupert
- via Kirsten Marie Kliphouse
-
Merck & Company Inc. Same sectorvia Paul Rothman
-
Tenaya Therapeutics Inc. Same sectorvia R. Sanders Williams
- via Kerrii B. Anderson
- via Kerrii B. Anderson
-
Xeris Biopharma Holdings Inc. Same sectorvia Garheng Kong
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $10,908,733
- 21 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Open-market sale | −306 | $353.70 | $108,232 |
| Nov 2, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Shares withheld for tax | −194 | $355.59 | $68,984 |
| Nov 2, 2026 | Oyegunwa Akinbolade Officer (EVP, CIO & CTO) | Shares withheld for tax | −118 | $355.59 | $41,960 |
| Nov 1, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Option exercise | +500 | — | — |
| Nov 1, 2026 | Oyegunwa Akinbolade Officer (EVP, CIO & CTO) | Option exercise | +370 | — | — |
| Oct 30, 2026 | Richelle P. Parham Director | Open-market sale | −1,078 | $361.22 | $389,395 |
| Aug 17, 2026 | Kerrii B. Anderson Director | Open-market sale | −3,000 | $318.02 | $954,060 |
| Aug 11, 2026 | Adam H. Schechter Director, Officer (President & CEO) | Open-market sale | −4,669 | $320.37 | $1,495,808 |
| Aug 4, 2026 | Summy Amy B. Officer (EVP, Chief Marketing Officer) | Open-market sale | −924 | $306.74 | $283,428 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Open-market sale | −82 | $309.22 | $25,356 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Option exercise | +1,338 | $209.25 | $279,977 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Open-market sale | −1,338 | $309.23 | $413,750 |
| Jul 2, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Open-market sale | −92 | $286.19 | $26,329 |
| Jul 2, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Open-market sale | −234 | $286.19 | $66,968 |
| Jul 1, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Option exercise | +256 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Labcorp Holdings Inc.
Who is the CEO of Labcorp Holdings Inc.?
Adam H. Schechter is Labcorp Holdings Inc.'s President & CEO.
How many directors are on Labcorp Holdings Inc.'s board?
Labcorp Holdings Inc.'s board has 14 directors: Adam H. Schechter, Carulla Victor Bulto, Dwight Gary Gilliland, Garheng Kong, Jean-Luc Belingard, Jeffrey A. Davis, John H. Sampson, Kathryn E. Wengel, Kerrii B. Anderson, Kirsten Marie Kliphouse and 4 others.
Are Labcorp Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Labcorp Holdings Inc. insiders made no open-market purchases and sold $10.9 million of shares in 21 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="labcorp-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.